insights_auto
Why is LZAGF up 3,37%?
Dive Deeperchevron_right
LZAGF:OTCMKTS
Lonza Group AG
USDÂ 705,45
arrow_upward
+3,37%(+23,00) 1D
12 Okt., 14:28:04 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LZAGF...
Open
USDÂ 679,28
High
USDÂ 705,45
Low
USDÂ 664,54
Mkt. cap
40,31Â mjd
Avg. vol.
219,00
Volume
474,00
52-wk high
USDÂ 755,96
52-wk low
USDÂ 565,14
Beta
1,00
Shares outstanding
70,23Â m
No. of employees
20Â k
Open
USDÂ 679,28
High
USDÂ 705,45
Low
USDÂ 664,54
Mkt. cap
40,31Â mjd
Avg. vol.
219,00
Volume
474,00
52-wk high
USDÂ 755,96
52-wk low
USDÂ 565,14
Beta
1,00
Shares outstanding
70,23Â m
No. of employees
20Â k
News stories
From web sources and news partners
TipRanks
·
6 uur gelede
Lonza Secures Exclusive CDK7 Inhibitor Rights to Boost Dual-Payload ADC Platform
ad-hoc-news.de
·
11 uur gelede
Lonza nominated Pearl Huang and Lonza Group stock costs EUR 614.90
ad-hoc-news.de
·
13 uur gelede
Lonza Group stock pre-market at EUR 615.90
Profile
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. Wikipedia
About Lonza Group AG
CEOWolfgang Wienand
Employees20,1Â k
Founded1897
HeadquartersBasel, Basel City, Switserland
SectorHealth care
Websitelonza.com